Revelation Biosciences, Inc. (REVB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.21M | -1.97M | -1.59M | -1.92M | -2.79M | -3.75M | -9.26M | -2.48M | -2.84M | -2M | -1.72M | -1.99M |
| Operating CF Margin % | - | - | - | - | - | -13898.68% | - | - | - | -5330.38% | - | - |
| Operating CF Growth % | -15.05% | 47.51% | 82.84% | 22.57% | 1.54% | -87.12% | -439.24% | -24.46% | -80.17% | -111.39% | 0.85% | 46.32% |
| Net Income | -3.01M | -2.51M | -1.91M | -2.44M | -2.05M | -1.73M | -2.24M | -8.39M | -2.68M | -2.2M | -2.63M | -1.45M |
| Depreciation & Amortization | 7.2K | 5.85K | 6.76K | 7.22K | 7.22K | 7.22K | 7.22K | 7.22K | 6.26K | 6.26K | 6.26K | 6.26K |
| Stock-Based Compensation | 0 | 370.17K | 874 | 873 | 223.46K | 72.57K | 32.09K | 32.09K | 32.09K | 32.09K | 32.1K | 59.44K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -62.96K | 0 |
| Other Non-Cash Items | 526.7K | 18.54K | 3.88K | -43 | 5.3K | -2.56K | -6.04K | 20.58K | -68.43K | -68.2K | -29.6K | -423.24K |
| Working Capital Changes | -739.7K | 149.45K | 306.76K | 517.05K | -979.3K | -2.1M | -7.05M | 5.85M | -126.47K | 229.91K | 965.9K | -185.9K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 216.9K | -442.45K | 191.06K | 203.84K | -158.56K | -2.34M | 1.85M | -400.34K | 321.77K | 28.72K | 343.36K | 208.78K |
| Cash from Investing | -71.88K | 0 | 0 | 0 | 0 | 17.69K | -17.69K | 0 | -19.17K | 0 | 0 | 0 |
| Capital Expenditures | -71.88K | 0 | 0 | 0 | 0 | 17.69K | -17.69K | 0 | -19.17K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 65.6% | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 6.7M | -41.17K | 9.12M | 3.39M | 0 | 3.69M | 3.74M | 0 | 5.42M | 0 | 0 | 15 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 6.7M | -41.17K | 9.12M | 3.39M | 0 | 3.69M | 3.74M | 0 | 5.42M | 0 | 0 | 15 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127 | 0 | 0 | 0 |
| Net Change in Cash | 3.41M | -2.01M | 7.53M | 1.47M | -2.79M | -42.03K | -5.53M | -2.48M | 2.56M | -2M | -1.72M | -1.99M |
| Free Cash Flow | -3.29M | -1.97M | -1.59M | -1.92M | -2.79M | -3.73M | -9.27M | -2.48M | -2.86M | -2M | -1.72M | -1.99M |
| FCF Margin % | - | - | - | - | - | -13833.07% | - | - | - | -5330.38% | - | - |
| FCF Growth % | -17.62% | 47.27% | 82.87% | 22.57% | 2.2% | -86.23% | -440.27% | -24.46% | -81.39% | -111.39% | 0.85% | 46.32% |
| FCF per Share | -1.02 | -3.17 | -0.60 | -2.39 | -2.88 | -10.76 | -55.37 | -24.25 | -41.95 | -121.14 | -130.85 | -164.49 |
| FCF Conversion (FCF/Net Income) | 1.07x | 0.78x | 0.83x | 0.79x | 1.36x | 2.17x | 4.13x | 0.30x | 1.06x | 0.91x | 0.65x | 1.38x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |